Pancreatic cancer action network - Join us
Clinical Trial
Finder
Retrieving Trials
Retrieving Trials...

Back to Trial Search

Phase I/II Study Of Nano-SMART: Nanoparticles With MR Guided SBRT In Centrally Located Lung Tumors and Pancreatic Cancer

Summary

The purpose of this phase I/II trial is to evaluate the safety and efficacy of gadolinium-based nanoparticle, Activation, and Guidance of Irradiation X (AGuIX), used in combination with MR-guided stereotactic body radiation therapy (SBRT) in patients with lung tumors and pancreatic cancer.

General Information

NCT#: NCT04789486
Study ID: 19-826
Trial Phase: Phase I/II

Trial Sponsor: Dana-Farber Cancer Institute
Therapies Used in This Trial: Stereotactic body radiotherapy (SBRT)

Request a Healthcare Provider account to access Trial Eligibility and Site Information.

View Details

An authorized Healthcare Provider account is required to access Trial Eligibility and Site Information. Already have an account?

Request an Account


  • In order to view this information, you need to be signed in as a Health Care Provider.
  • You need to be signed in as a Health Care Provider. Please request an account.
  • In order to view this information, you need to be signed in as a Health Care Provider.
  • In order to see the trial eligibility criteria, you need to be signed in as a Health Care Provider.
  • This information is restricted to validated Health Care Providers.

Eligibility



-------------------------------------------------------------------------------------------

  • In order to view this information, you need to be signed in as a Health Care Provider.
  • You need to be signed in as a Health Care Provider. Please request an account by clicking on the Request button.
  • ------------------------------------------------------------------------------------------------------
  • In order to view this information, you need to be signed in as a Health Care Provider. You are currently not authorized.

Site Information


Back to Trial Search